结构:c1ccc([As](c2ccccc2)c2ccccc2)cc1
HCID11773

Triphenylarsine

triphenylarsane

C18H15As306.2 g/molCAS 603-32-7

IDENTITY

结构与身份

标准 SMILES
c1ccc([As](c2ccccc2)c2ccccc2)cc1
InChIKey
BPLUKJNHPBNVQL-UHFFFAOYSA-N
分子式
C18H15As
平均分子量
306.2 g/mol
单同位素质量
306.03897

COMPUTED

结构计算性质

已同步
极性表面积
0 Ų
氢键供体
0
氢键受体
0
可旋转键
3
重原子
19
形式电荷
0
复杂度
202

PROPERTIES

实验与物化性质

来源:PubChem
Vapor Pressure

0.0000496 [mmHg]

Physical Description

White powder; [Alfa Aesar MSDS] Fine colorless crystals; [Aldrich MSDS]

Kovats Retention Index

2195

GHS

GHS 分类

来源:PubChem
GHS Classification

Danger

H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral];H331 (100%): Toxic if inhaled [Danger Acute toxicity, inhalation];H400 (90.9%): Very toxic to aquatic life [Warning Hazardous to the aquatic environment, acute hazard];H410 (100%): Very toxic to aquatic life with long lasting effects [Warning Hazardous to the aquatic environment, long-term hazard]

P261, P264, P270, P271, P273, P301+P316, P304+P340, P316, P321, P330, P391, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 44 reports by companies from 4 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.;Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.

HAZARDS

危害信息

来源:PubChem
Regulatory Information

Restricted substance: Triphenylarsine;EC: 210-032-9;Restriction condition document: PDF link

Triphenylarsine: Does not have an individual approval but may be used under an appropriate group standard

Hazards Summary

An irritant; Toxic by ingestion and inhalation; [Alfa Aesar MSDS] Almost nothing is known regarding health effects of organic arsenic compounds in humans. Studies in animals show that some simple organic arsenic compounds are less toxic than inorganic forms. Ingestion of methyl and dimethyl compounds can cause diarrhea and damage to the kidneys. [ATSDR ToxProfiles] See Dimethylarsenic acid.

Hazard Classes and Categories

Acute Tox. 3 (100%);Acute Tox. 3 (100%);Aquatic Acute 1 (90.9%);Aquatic Chronic 1 (100%)

SAFETY

安全与防护

来源:PubChem
Minimum Risk Level

Acute Oral: 0.005 mg/kg/day (L134) Chronic Oral: 0.0003 mg/kg/day (L134) Chronic Inhalation: 0.01 mg/m3 (L134)

Permissible Exposure Limit (PEL)

0.5 [mg/m3], as As

TOXICITY

毒理信息

来源:PubChem
Treatment

Arsenic poisoning can be treated by chelation therapy, using chelating agents such as dimercaprol, EDTA or DMSA. Charcoal tablets may also be used for less severe cases. In addition, maintaining a diet high in sulfur helps eliminate arsenic from the body. (L20)

Health Effects

Arsenic poisoning can lead to death from multi-system organ failure, probably from necrotic cell death, not apoptosis. Arsenic is also a known carcinogen, esepcially in skin, liver, bladder and lung cancers. (T1, L20)

Exposure Routes

Oral (L2) ; inhalation (L2) ; dermal (L2)

Toxicity Summary

Arsenic and its metabolites disrupt ATP production through several mechanisms. At the level of the citric acid cycle, arsenic inhibits pyruvate dehydrogenase and by competing with phosphate it uncouples oxidative phosphorylation, thus inhibiting energy-linked reduction of NAD+, mitochondrial respiration, and ATP synthesis. Hydrogen peroxide production is also increased, which might form reactive oxygen species and oxidative stress. Arsenic's carginogenicity is influenced by the arsenical binding of tubulin, which results in aneuploidy, polyploidy and mitotic arrests. The binding of other arsenic protein targets may also cause altered DNA repair enzyme activity, altered DNA methylation patterns and cell proliferation. (T1, A17)

Signs and Symptoms

Exposure to lower levels of arsenic can cause nausea and vomiting, decreased production of red and white blood cells, abnormal heart rhythm, damage to blood vessels, and a sensation of

Carcinogen Classification

3, not classifiable as to its carcinogenicity to humans. (L135)

REGULATORY

法规信息

来源:PubChem
Regulatory Information

Restricted substance: Triphenylarsine;EC: 210-032-9;Restriction condition document: PDF link

Triphenylarsine: Does not have an individual approval but may be used under an appropriate group standard

PHARMACOLOGY

药理信息

来源:PubChem
Metabolism/Metabolites

Arsenic is absorbed mainly by inhalation or ingestion, as to a lesser extent, dermal exposure. It is then distributed throughout the body, where it is reduced into arsenite if necessary, then methylated into monomethylarsenic (MMA) and dimethylarsenic acid (DMA) by arsenite methyltransferase. Arsenic and its metabolites are primarily excreted in the urine. Arsenic is known to induce the metal-binding protein metallothionein, which decreases the toxic effects of arsenic and other metals by binding them and making them biologically inactive, as well as acting as an antioxidant. (L20)

USES

用途与制造

来源:PubChem
Uses

Triphenylarsine is used as a ligand and a reagent in coordination chemistry and organic synthesis. (L398)

General Manufacturing Information

Arsine, triphenyl-: ACTIVE

ALIASES

名称与别名

38
TRIPHENYLARSINETriphenylarsane603-32-7Arsine, triphenyl-TriphenylarseneTriphenyl arsenicMN8EZ3FL74NSC-478DTXSID4060529RefChem:191898DTXCID6042787210-032-9ArsinetriphenylMFCD00002994TriphenylarsenicNSC 478Arsenic triphenylC18H15AsEINECS 210-032-9UNII-MN8EZ3FL74

REACTIONS

参与反应

190
HRID86008

Training data from https://doi.org/10.1039/C8SC04228D (2/10)

作为反应物
HRID 86008 方程式

Training data from https://doi.org/10.1039/C8SC04228D (2/10) · 10.1039/C8SC04228D

查看条件与参与物
HRID91724

Training data from https://doi.org/10.1039/C8SC04228D (2/10)

作为反应物
HRID 91724 方程式

Training data from https://doi.org/10.1039/C8SC04228D (2/10) · 10.1039/C8SC04228D

查看条件与参与物